Brief: Epigenomics AG Says CMS accepts Epigenomics' application for NCD review
03/05/2019 02:40
May 2 (Reuters) - Epigenomics AG ECXn.DE :
* EPIGENOMICS AG - CENTERS FOR MEDICARE & MEDICAID SERVICES
ACCEPTED CO'S APPLICATION FOR A NATIONAL COVERAGE DETERMINATION
REVIEW OF EPI PROCOLON
Source text for Eikon: ID:nEQ31YcPQa
Further company coverage: ECXn.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns